Stockscreener 앱 받기
28.70
4.90%
-1.48
시간 외 거래:
28.70
전일 마감가:
$30.18
열려 있는:
$30.22
하루 거래량:
1.97M
Relative Volume:
2.37
시가총액:
$1.45B
수익:
$534.53M
순이익/손실:
$-11.45M
주가수익비율:
-119.04
EPS:
-0.2411
순현금흐름:
$48.28M
1주 성능:
+0.91%
1개월 성능:
+3.72%
6개월 성능:
-29.00%
1년 성능:
-11.09%
1일 변동 폭
$27.24
$30.78
1주일 범위
$27.24
$30.78
52주 변동 폭
$25.36
$43.18
Atricure Inc Stock (ATRC) Company Profile
명칭
Atricure Inc
전화
513-755-4100
주소
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
28.70 | 1.53B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
405.97 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
155.19 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.61 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.61 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
198.43 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-18 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2026-02-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-12-17 | 재개 | JP Morgan | Overweight |
| 2024-04-23 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-29 | 개시 | UBS | Buy |
| 2021-08-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 재확인 | Needham | Buy |
| 2020-11-06 | 재확인 | Needham | Buy |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-24 | 재확인 | Needham | Buy |
| 2019-08-13 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | 개시 | JP Morgan | Overweight |
| 2018-10-04 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Stifel | Buy |
| 2018-06-18 | 재확인 | Needham | Buy |
| 2018-04-27 | 재확인 | Needham | Buy |
| 2018-01-16 | 재확인 | Needham | Buy |
| 2017-11-02 | 재확인 | Needham | Buy |
| 2017-07-28 | 재확인 | Needham | Buy |
| 2017-05-30 | 재개 | Piper Jaffray | Overweight |
| 2016-06-30 | 재개 | JMP Securities | Mkt Outperform |
| 2015-10-28 | 재확인 | Needham | Buy |
| 2015-10-06 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-06 | 재확인 | Needham | Buy |
모두보기
Atricure Inc 주식(ATRC)의 최신 뉴스
AtriCure (ATRC) Joins Multiple Russell 2000 Defensive Indexes Is Its Risk Profile Evolving? - simplywall.st
Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic - MedTech Dive
AtriCure, Inc. Actuals & Estimates (NASDAQ:ATRC) - TradingView
AtriCure, Inc. Actuals & Estimates (DUS:A5I) - TradingView
ATRC Forecast — Price Target — Prediction for 2027 - TradingView
How (ATRC) Movements Inform Risk Allocation Models - Stock Traders Daily
AtriCure Inc (ATRC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AtriCure (ATRC) Soars 6.2%: Is Further Upside Left in the Stock? - Yahoo Finance
AtriCure Inc (ATRC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AtriCure Inc (ATRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AtriCure Inc (ATRC) Institutional Confidence - TradingKey
AtriCure Inc (ATRC) Valuation: PE, PB & Fair Value Analysis - TradingKey
AtriCure Inc (ATRC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AtriCure Inc (ATRC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AtriCure Inc (ATRC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AtriCure Inc (ATRC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Trading Systems Reacting to (ATRC) Volatility - Stock Traders Daily
Do options traders know something about AtriCure stock we don't? - MSN
AtriCure (ATRC) Q1 2026 Earnings Transcript - AOL.com
Do Options Traders Know Something About AtriCure Stock We Don't? - Yahoo Finance
AtriCure (ATRC) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
A Look At AtriCure (ATRC) Valuation As BoxX NoAF Trial Acceleration Draws Investor Attention - Yahoo Finance
AtriCure faces market doubts despite revenue growth; share prices fall. Insider optimism hints at potential turnaround, but long-term earnings are the focus. - Moomoo
AtriCure (ATRC) Advances Key Heart Disease Trial 12 Months Ahead of Schedule - Insider Monkey
AtriCure, Inc. Hits 52-Week Low at USD 25.37 Amid Market Struggles - Markets Mojo
AtriCure stock hits 52-week low at 25.51 USD By Investing.com - Investing.com Australia
AtriCure stock hits 52-week low at 25.51 USD - Investing.com
Top 10 Small Cap Stocks With Huge Growth Potential - Insider Monkey
AtriCure Inc. (ATRC) Slips 1.5% as Stock Hovers Near Key Support at $26.29Chart Pattern Alerts - The Legal Advocate
AtriCure to Participate in the Goldman Sachs 47th Annual Global Health Care Conference - Yahoo Finance
Insider Sell Alert: Karen Prange Sells 3,000 Shares of AtriCure Inc (ATRC) - GuruFocus
(ATRC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
AtriCure director Karen Prange sells $85,950 in company stock By Investing.com - Investing.com Canada
AtriCure director Karen Prange sells $85,950 in company stock - Investing.com
AtriCure (ATRC) director Prange sells 3,000 shares, keeps 26,373 - Stock Titan
Director Karen Prange granted 6,144 AtriCure (ATRC) shares - Stock Titan
AtriCure (ATRC) director Deborah Telman awarded 6,144 restricted shares - Stock Titan
AtriCure (ATRC) director Maggie Yuen receives 6,144-share restricted stock award - Stock Titan
Director Nachman Shlomo receives 6,144 AtriCure (ATRC) restricted shares - Stock Titan
Director Kristine Johnson receives 6,144-share grant at AtriCure (ATRC) - Stock Titan
AtriCure (ATRC) director Regina Groves receives 6,144-share restricted stock grant - Stock Titan
AtriCure (ATRC) director Sven Wehrwein receives 6,144-share restricted stock grant - Stock Titan
Director at AtriCure (ATRC) receives 6,144-share restricted stock grant - Stock Titan
[144] AtriCure, Inc. SEC Filing - Stock Titan
AtriCure Shareholders Approve Expanded Equity and Governance Plans - TipRanks
AtriCure (ATRC) stockholders back equity plan share increases and director slate - Stock Titan
AtriCure conference: New devices, EnCompass drive 2026 growth outlook - MSN
Insider Sell: Vinayak Doraiswamy Sells 5,000 Shares of AtriCure Inc (ATRC) - GuruFocus
Atricure Inc (ATRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.09%
0.52%
자본화:
|
볼륨(24시간):